Abstract
Background. Neurally Adjusted Ventilatory Assist (NAVA) is a ventilator mode providing improved patient-ventilator synchrony compared to flow- or pressure-triggered modes. We examined the effect of various NAVA, Pressure Support (PSV) and Positive End Expiratory Pressure (PEEP) combinations in infants with acute viral bronchiolitis.
Methods. Mechanistic study, nested within a randomized controlled feasibility trial. A set of sixteen ventilatory combinations (each of 10-15 minutes), including PEEP of 1, 5 and 10 cmH2O, PSV of 20 cmH2O and NAVA support ranging from 0.5-2.0 cmH2O/microvolt, were administered on each of two consecutive days to thirteen invasively ventilated infants: mean (range) age 4 months (0.1 to 10.0).
Outcome measures were grouped according to respiratory drive, respiratory efficiency, expiratory airflow limitation, gas exchange and tolerability.
Results. Higher PEEP levels were associated with better respiratory drive (P<0.001 for electrical activity of the diaphragm and P0.1), respiratory efficiency (higher tidal volumes and lower breathing frequency, both P<0.001) and improved oxygenation (P=0.02). Minute ventilation remained constant (P=0.67), as did transcutaneous CO2 (P=0.60). Expiratory airflow limitation was minimal overall;
however, it was reduced on NAVA compared to PSV (P<0.001 for Beta angle). A NAVA support of 0.5 cmH2O/microvolt appeared inadequate for some outcome measures; conversely, the benefit of increasing support beyond 1.0 was modest, and not always apparent across all outcome measures. Altering PEEP did not produce clinically adverse effects on hemodynamics or patient tolerability
(COMFORT-B score).
Conclusions. Higher PEEP values of up to 10 cmH2O may improve respiratory mechanics in acute viral bronchiolitis, without impacting adversely on clinical state. We could not identify an optimal NAVA support; however, 0.5 cmH2O/microvolt may be inadequate.
Methods. Mechanistic study, nested within a randomized controlled feasibility trial. A set of sixteen ventilatory combinations (each of 10-15 minutes), including PEEP of 1, 5 and 10 cmH2O, PSV of 20 cmH2O and NAVA support ranging from 0.5-2.0 cmH2O/microvolt, were administered on each of two consecutive days to thirteen invasively ventilated infants: mean (range) age 4 months (0.1 to 10.0).
Outcome measures were grouped according to respiratory drive, respiratory efficiency, expiratory airflow limitation, gas exchange and tolerability.
Results. Higher PEEP levels were associated with better respiratory drive (P<0.001 for electrical activity of the diaphragm and P0.1), respiratory efficiency (higher tidal volumes and lower breathing frequency, both P<0.001) and improved oxygenation (P=0.02). Minute ventilation remained constant (P=0.67), as did transcutaneous CO2 (P=0.60). Expiratory airflow limitation was minimal overall;
however, it was reduced on NAVA compared to PSV (P<0.001 for Beta angle). A NAVA support of 0.5 cmH2O/microvolt appeared inadequate for some outcome measures; conversely, the benefit of increasing support beyond 1.0 was modest, and not always apparent across all outcome measures. Altering PEEP did not produce clinically adverse effects on hemodynamics or patient tolerability
(COMFORT-B score).
Conclusions. Higher PEEP values of up to 10 cmH2O may improve respiratory mechanics in acute viral bronchiolitis, without impacting adversely on clinical state. We could not identify an optimal NAVA support; however, 0.5 cmH2O/microvolt may be inadequate.
| Original language | English |
|---|---|
| Pages (from-to) | 263-271 |
| Number of pages | 9 |
| Journal | Respiratory Care |
| Volume | 71 |
| Issue number | 3 |
| Early online date | 29 Oct 2025 |
| DOIs | |
| Publication status | E-pub ahead of print - 29 Oct 2025 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver